Universal Display Corporation 10-Q Summary
Business Context and Reporting Period
Universal Display Corporation develops, licenses and commercializes OLED technologies and materials for display and lighting applications. Revenue is primarily generated from OLED material sales, intellectual-property licensing and royalties, with additional contract research and technology-support services through Adesis. This unaudited Form 10-Q covers the three and nine months ended September 30, 2019, compared with the corresponding 2018 periods.
Financial Performance and Position
| Metric | Q3 2019 | Q3 2018 | 9M 2019 | 9M 2018 |
|---|---|---|---|---|
| Revenue | $97.5 million | $77.6 million | $303.4 million | $177.3 million |
| Gross margin | $80.2 million | $61.4 million | $246.3 million | $142.1 million |
| Gross margin percentage | 82% | 79% | 81% | 80% |
| Operating income | $40.8 million | $26.0 million | $123.9 million | $41.5 million |
| Net income | $37.0 million | $22.8 million | $111.9 million | $39.6 million |
| Diluted EPS | $0.78 | $0.48 | $2.36 | $0.83 |
| Operating cash flow | Not separately provided | Not separately provided | $137.7 million | $95.0 million |
- Q3 revenue increased 26% year over year, while nine-month revenue increased 71%, driven by higher OLED material sales and stronger OLED display demand.
- Q3 operating margin was approximately 42%; nine-month operating margin was approximately 41%.
- Q3 net margin was approximately 38%; nine-month net margin was approximately 37%.
- Research and development expense increased to $16.8 million in Q3 and $51.4 million for nine months, primarily from higher employee-related compensation and operating costs.
- Royalty and license expense increased to $2.8 million in Q3 and $8.8 million for nine months, reflecting higher qualifying material sales under the Princeton, USC and Michigan license arrangements.
- Interest income increased to $2.7 million in Q3 and $8.3 million for nine months due to higher investment balances.
- At September 30, 2019, cash and cash equivalents were $235.5 million and short-term investments were $361.5 million, totaling $597.0 million versus $515.3 million at December 31, 2018.
- Working capital was $582.6 million, compared with $501.7 million at year-end 2018.
- The filing presents no debt balance; liabilities primarily comprise deferred revenue, operating lease liabilities, retirement obligations and other operating liabilities. Total liabilities were $276.0 million and shareholders’ equity was $786.6 million.
- Inventory declined to $57.8 million from $70.0 million at December 31, 2018. The company recorded a $4.2 million inventory reserve increase during the first nine months of 2019.
- The company paid $14.1 million in common-stock dividends during the first nine months and declared an additional $0.10-per-share fourth-quarter dividend payable December 31, 2019.
Material Changes Versus the Prior Comparable Period
- Nine-month revenue increased by $126.2 million, and net income increased by $72.3 million.
- Nine-month gross margin percentage improved to 81% from 80%, despite higher cost of sales associated with increased material volumes.
- Operating income increased by $82.4 million for the first nine months, benefiting from revenue growth and operating leverage.
- Nine-month research and development expense increased $12.5 million and selling, general and administrative expense increased $6.1 million.
- Cash provided by operating activities increased $42.8 million year over year, primarily reflecting higher net income and increased deferred revenue.
- Investing cash use decreased to $83.2 million from $106.2 million, although the company continued to invest in securities, property and equipment and facility expansion.
- The company purchased adjacent property in Ewing, New Jersey, adding approximately 88,000 square feet for research, manufacturing logistics and corporate functions.
- Effective January 1, 2019, the company adopted ASC 842 for leases, recognizing operating lease right-of-use assets and liabilities of approximately $8.3 million at adoption.
- Revenue concentration remained significant: one customer represented 56% of Q3 revenue and 45% of nine-month revenue; three customers collectively represented approximately 89% of Q3 revenue and 86% of nine-month revenue.
Guidance, Outlook, Risks and Unusual Items
- Management did not provide specific numerical revenue or earnings guidance in the filing. It stated that results may fluctuate based on OLED material demand, timing of license fees and royalties, research and development and patent expenditures, and new business relationships.
- Management expects existing cash, cash equivalents and short-term investments to be sufficient to meet obligations for at least the next twelve months.
- Revenue is highly concentrated geographically and by customer. Approximately 97% of revenue came from outside North America, principally South Korea and China.
- Revenue recognition depends on estimates of material volumes, customer sales-based royalties and contract transaction prices. Changes in those estimates can affect reported revenue and deferred revenue.
- The company depends substantially on one chemical-material supplier and had $23.6 million of firm inventory purchase commitments at September 30, 2019.
- An opposition proceeding remains pending before the European Patent Office concerning European Patent No. 1390962, relating to white phosphorescent OLED technology. The company is appealing a prior revocation decision and cannot assure a favorable outcome.
- The company is pursuing potential refunds of Korean withholding taxes and related tax positions. The balance sheet includes significant long-term tax assets and liabilities associated with these matters, and management notes that estimates may change upon settlement.
- A $1.9 million deferred tax liability release related to expiration of the statute of limitations for the 2015 federal tax return reduced Q3 2019 tax expense. Management also reported $3.5 million of year-to-date tax benefits from excess deductions on employee share awards.
- The company reported no material changes to previously disclosed risk factors, no material off-balance-sheet arrangements and effective disclosure controls as of September 30, 2019.
Important Facts for Investors to Verify
- Whether OLED display demand and customer production levels support the sharp year-over-year increase in material sales.
- The sustainability of revenue concentration, particularly the contribution of the customer representing 56% of Q3 revenue.
- The assumptions used in estimating customer material volumes, royalties and the recognition of deferred revenue.
- The status and potential financial impact of the European Patent Office appeal involving Patent No. 1390962.
- The recoverability and ultimate resolution of the Korean withholding-tax claims and related tax positions.
- Inventory utilization, the $4.2 million year-to-date inventory reserve increase and the $23.6 million of supplier purchase commitments.
- Future capital spending and operating costs associated with the Ewing, New Jersey expansion.
- The absence of formal numerical guidance and management’s liquidity forecast supporting at least twelve months of operations.